Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD)

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Soler Artigas, María|||0000-0002-3213-1107
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Llonga, Natalia|||0000-0003-4325-6201
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder that results from the interaction of both genetic and environmental risk factors. Genome-wide association studies have started to identify multiple genetic risk loci associated with ADHD, however, the exact causal genes and biological mechanisms remain largely unknown. We performed a multi-step analysis to identify and characterize modules of co-expressed genes associated with ADHD using data from peripheral blood mononuclear cells of 270 ADHD cases and 279 controls. We identified seven ADHD-associated modules of co-expressed genes, some of them enriched in both genetic and epigenetic signatures for ADHD and in biological pathways relevant for psychiatric disorders, such as the regulation of gene expression, epigenetics and immune system. In addition, for some of the modules, we found evidence of potential regulatory mechanisms, including microRNAs and common genetic variants. In conclusion, our results point to promising genes and pathways for ADHD, supporting the use of peripheral blood to assess gene expression signatures in psychiatric disorders. Furthermore, they highlight that the combination of multi-omics signals provides deeper and broader insights into the biological mechanisms underlying ADHD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Demontis, Ditte|||0000-0001-9124-2766
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores

  • GRAU-LÓPEZ, LARA
  • Daigre, Constanza
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Heterogeneity; Substance use disorder; Genome, Heterogeneidad; Trastorno por consumo de sustancias; Genoma, Heterogeneïtat; Trastorn per consum de substàncies; Genoma, Substance use disorder (SUD) is a global health problem with a significant impact on individuals and society. The presentation of SUD is diverse, involving various substances, ages at onset, comorbid conditions, and disease trajectories. Current treatments for SUD struggle to address this heterogeneity, resulting in high relapse rates. SUD often co-occurs with other psychiatric and mental health-related conditions that contribute to the heterogeneity of the disorder and predispose to adverse disease trajectories. Family and genetic studies highlight the role of genetic and environmental factors in the course of SUD, and point to a shared genetic liability between SUDs and comorbid psychopathology. In this study, we aimed to disentangle SUD heterogeneity using a deeply phenotyped SUD cohort and polygenic scores (PGSs) for psychiatric disorders and related traits. We explored associations between PGSs and various SUD-related phenotypes, as well as PGS-environment interactions using information on lifetime emotional, physical, and/or sexual abuse. Our results identify clusters of individuals who exhibit differences in their phenotypic profile and reveal different patterns of associations between SUD-related phenotypes and the genetic liability for mental health-related traits, which may help explain part of the heterogeneity observed in SUD. In our SUD sample, we found associations linking the genetic liability for attention-deficit hyperactivity disorder (ADHD) with lower educational attainment, the genetic liability for post-traumatic stress disorder (PTSD) with higher rates of unemployment, the genetic liability for educational attainment with lower rates of criminal records and unemployment, and the genetic liability for well-being with lower rates of outpatient treatments and fewer problems related to family and social relationships. We also found evidence of PGS-environment interactions showing that genetic liability for suicide attempts worsened the psychiatric status in SUD individuals with a history of emotional physical and/or sexual abuse. Collectively, these data contribute to a better understanding of the role of genetic liability for mental health-related conditions and adverse life experiences in SUD heterogeneity., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840 and 2021-SGR-01093), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to M.S.A, RYC2021-031324-I to J.C.D and PID2021-1277760B-I100 to B.C. and N.F-C.), the Ministry of Health, Social Services and Equality (PNSD-2020I042 to N.F-C.), the Network Center for Biomedical Research (CIBER) to J.C.D., the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’, “Fundació La Marató de TV3” (202228-30, 202228-31 and 202218-31) and ICREA Academia 2021.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).